Adamantinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Apr 2025Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Nanfang Hospital, Southern Medical University — PHASE1, PHASE2

TrialRECRUITING
May 2023FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc. — PHASE1, PHASE2

TrialRECRUITING
Apr 2023MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital — PHASE2

TrialRECRUITING
Dec 2022ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital — PHASE2

TrialRECRUITING
Sep 2019Tocilizumab in Children With ACP

University of Colorado, Denver — EARLY_PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Adamantinoma.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials
2Phase 2
1PHASE1, PHASE2
1EARLY_PHASE1
4Total recruiting
Search clinical trials for Adamantinoma

Recent News & Research

No recent news articles indexed yet for Adamantinoma.
Search PubMed for Adamantinoma

Browse all Adamantinoma news →

Specialist Network

Top 6 by expertise

View all Adamantinoma specialists →

Quick Actions